Cargando…

Sleep disorders in Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Hawken, Jonathan, Robertson, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618532/ https://www.ncbi.nlm.nih.gov/pubmed/36190551 http://dx.doi.org/10.1007/s00415-022-11403-5

Ejemplares similares

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

The gut microbiome: neurological development and disease
por: Miah, Latif, et al.
Publicado: (2022)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease
por: Kinghorn, Kerri J.
Publicado: (2011)

Socioeconomic status in neurological disorders: a modifiable risk factor?
por: Hrastelj, J., et al.
Publicado: (2022)

Advances in Tourette’s syndrome
por: Robertson, Neil P.
Publicado: (2023)

Parkin’ control: regulation of PGC-1α through PARIS in Parkinson’s disease
por: Castillo-Quan, Jorge Iván
Publicado: (2011)

Ice bucket challenge bears fruit for amyotrophic lateral sclerosis
por: Hrastelj, James, et al.
Publicado: (2016)

Transmissible amyloid protein: evidence from iatrogenic CJD
por: Hu, Mo, et al.
Publicado: (2018)

Monoclonal antibodies for migraine: an update
por: Castle, Daniel, et al.
Publicado: (2018)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Parkinson, Alzheimer und MS in Coronazeiten
por: Wietelmann, Detlef
Publicado: (2021)

Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
por: Fung, W., et al.
Publicado: (2018)

Clinical trials for cerebellar ataxia
por: Schroeder, Benjamin E., et al.
Publicado: (2022)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

Deep brain stimulation for dystonia
por: Harding, Katharine E., et al.
Publicado: (2016)

An update on treatments in myasthenia gravis
por: Jones, Lliwen A., et al.
Publicado: (2016)

The consequences of valproate exposure in utero
por: Thomas, Rhys H., et al.
Publicado: (2016)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

What can rare variant genetics tell us about cognition and intellectual difficulties?
por: Thomas, Rhys H., et al.
Publicado: (2016)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

New rare genetic variants in multiple sclerosis
por: Harding, Katharine E., et al.
Publicado: (2018)

The role of TSPO PET in assessing neuroinflammation
por: Crawshaw, Ania A., et al.
Publicado: (2017)

Spontaneous intracranial hypotension: features, diagnosis and management
por: Massey, Tom H., et al.
Publicado: (2021)

Medication-overuse headache: causes, consequences and management
por: Massey, Thomas H., et al.
Publicado: (2021)

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Advances in the genetics of stroke risk and recovery
por: Majumder, Sabbiha Nadia, et al.
Publicado: (2022)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dphbmlh7qft5l4pq8ahk3ir41p